Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Beraprost modified release - Astellas Pharma/Kaken Pharmaceuticals/Toray Industries

Next Previous
X
Search
Drug Profile

Beraprost modified release - Astellas Pharma/Kaken Pharmaceuticals/Toray Industries

Alternative Names: Beraprost controlled release; Beraprost MR - Astellas Pharma/Kaken Pharmaceuticals/Toray Industries; Beraprost sustained release; Beraprost-SR; Berasus; Careload LA; TRK-100STP; YM 533

Latest Information Update: 05 Nov 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Toray
  • Developer Astellas Pharma; Kaken Pharmaceutical; Toray
  • Class 3-ring heterocyclic compounds; Alkynes; Antiplatelets; Benzofurans; Butyric acids; Cyclopentanes; Prostaglandins; Small molecules; Vasodilators
  • Mechanism of Action Epoprostenol receptor agonists; Platelet aggregation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Pulmonary arterial hypertension
  • Discontinued Renal failure; Spinal stenosis

Most Recent Events

  • 01 Aug 2014 Toray and Astellas complete a phase II/III trial in Renal failure in China, Hong Kong, Japan, Malaysia, South Korea, Taiwan and Thailand (NCT01090037)
  • 01 Feb 2014 Toray Industries completes a phase I trial in Renal impairment in Japan (NCT01443429)
  • 01 May 2008 Toray completes enrolment in its phase II trial for Renal failure in Japan (NCT02480751)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top